Drugs / Sabin Strain Inactivated Poliovirus Vaccine (Vero cell)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06442449 | Aug 2024 → Sep 2025 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin Strain Inactivated Poliovirus Vaccine (Vero cell) | “This is an Open-labeled, Randomized, Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of Booster Dose of Sabin Strain Inactivated Poliovirus Vaccine...” NCT06442449 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06442449 ↗ |
| Modality | Vaccine | “Sabin Strain Inactivated Poliovirus Vaccine (Vero cell) (sIPV)” NCT06442449 ↗ |